Imperium Technology Group Limited (IPGGF) explained One stock would be nice but you have to put a big chunk on it and KNOW it is the ONE for that retirement gain. But thats OK, theyre kidding too still worth a look . This particular ad is for his Green Zone Fortunes, an entry level letter ($47/yr) that profiles one stock thats in the zone each month. I have a hard time taking the company seriously after looking at previous teases, but I guess nothing is impossible the best quick overview is probably from their investor presentation last summer if youd like to learn a little more about the company. Already, some of those companies are outperforming the market partly because of the coronavirus pandemic and he expects this to continue moving forward. When I first spotted this stock they were $1Theyre now over $3 and dont look like stopping. of Tucson, AZ. He thinks that it could spark the DNA sequencing trend that will lead to mass adoption. I believe that genetics has a very minute part in the diseases that plague us. Imperium aka The Unstoppable Stock Market Juggernaut of 2021 is a legit presentation by Adam ODell. If you look at the work of the True North Health Center, you can see multiple cases of people doing doctor supervised extended fasts that left them in remission from cancer. Their number one product is currently in an FDA-approved trial to see if it works as a therapeutic for long haul COVID-19. Bill Gates' investment fund is contributing to a $429 million investment saying Imperium is " one of the most powerful technologies of the 21st century ". He starts out with what looks like a blueprint of a special machine. This remains one of our most-requested stories, and the ad includes a few bonus small cap stock ideas, so I updating it at the beginning of 2022 with, for the first time, some solutions for those bonus ideas. I will not trade in any covered stock for at least three days, per Stock Gumshoes trading rules. I cant claim to understand the technology very well, Im afraid, but the financials have been ramping up nicely, with a boost from COVID-related work giving them a little revenue jolt last year and getting them over $100 million in sales for the first time, though theyre still a ways from reaching commercial scale even with their largest business, the next generation sequencing materials and services and the more revolutionary stuff that is really the focus of the company, including their synthetic biology products, drug development from their discoveries that might end up generating royalties, and the potential for using their DNA on a chip technology for data storage, seem to me to be mostly 5+ years in the future stories.